Peter Sinn

Robust gridding of TMAs after whole‐slide imaging using template matching

Hartmut Dickhaus, Dirk Jäger, Bernd Lahrmann, 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Deep Learning for the Classification of Small-Cell and Non-Small-Cell Lung Cancer

Michael Thomas, Cleo-Aron Weis, Claus Peter Heussel, 2020, Cancers.

High‐throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium

Peter Devilee, Arto Mannermaa, Annegien Broeks, 2016, The journal of pathology. Clinical research.

PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancer.

Carsten Denkert, Peter A Fasching, Andreas Schneeweiss, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers.

Carsten Denkert, Stephan Wienert, Frederick Klauschen, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group

Carsten Denkert, Jan Budczies, David L Rimm, 2016, Modern Pathology.

Plasma MicroRNA Panel for Minimally Invasive Detection of Breast Cancer

Michael Golatta, Barbara Burwinkel, Manuela Zucknick, 2013, PloS one.

Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences

Carsten Denkert, Jan Budczies, Nicole Pfarr, 2014, Oncotarget.